NCT02797093View on ClinicalTrials.gov

Impact of ART Adherence on HIV Persistence and Inflammation

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 12, 2018

Study Completion Date

October 12, 2018

Conditions
Human Immunodeficiency Virus
Trial Locations (1)

80045

University of Colorado, Denver, Aurora

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Colorado, Denver

OTHER

NCT02797093 - Impact of ART Adherence on HIV Persistence and Inflammation | Biotech Hunter | Biotech Hunter